Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRDX | Common Stock | Sale | -$175K | -3.9K | -2.45% | $44.97 | 155K | Apr 1, 2022 | Direct | F1, F2, F3 |
transaction | SRDX | Common Stock | Sale | -$4.56K | -100 | -0.06% | $45.55 | 155K | Apr 1, 2022 | Direct | F1 |
Id | Content |
---|---|
F1 | Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. |
F2 | Reflects the weighted average price of 3,900 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on April 1, 2022 with sale prices ranging from $44.49 to $45.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F3 | Includes 308 shares acquired through the Employee Stock Purchase Plan for the phase ending 2/28/22. |